HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elimination of small ruminant lentivirus infection from sheep flocks and goat herds aided by health schemes in Great Britain.

Abstract
Over a period of 11 years, 33 sheep or goat holdings lost their maedi-visna or caprine arthritis-encephalitis accredited status (mean 2.8 per year [0.09 per cent] of the accredited holdings in Great Britain). Of these, 22 sheep flocks and two goat herds eradicated the infection and regained their accredited status. In addition, 10 sheep flocks and two goat herds managed to eradicate infection, having joined the scheme with infected animals. In flocks and herds with a high initial prevalence of infection, the adoption of an indirect ELISA, with greater sensitivity than the agar gel immunodiffusion test, improved success rates. A strategy was devised to interpret the ELISA results depending upon the prevalence of infection at the time. Eighteen of the 33 flocks/herds (54.5 per cent) that had introductions of infection also owned non-accredited stock.
AuthorsB A Synge, C M Ritchie
JournalThe Veterinary record (Vet Rec) Vol. 167 Issue 19 Pg. 739-43 (Nov 06 2010) ISSN: 2042-7670 [Electronic] England
PMID21257509 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Animals
  • Antibodies, Viral (blood)
  • Arthritis-Encephalitis Virus, Caprine (immunology)
  • Enzyme-Linked Immunosorbent Assay (standards, veterinary)
  • Female
  • Goat Diseases (blood, diagnosis, epidemiology)
  • Goats
  • Immunodiffusion
  • Lentivirus Infections (blood, epidemiology, prevention & control, veterinary)
  • Male
  • Sensitivity and Specificity
  • Sheep
  • Sheep Diseases (blood, diagnosis, epidemiology)
  • United Kingdom (epidemiology)
  • Visna-maedi virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: